These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34024177)

  • 1. Clinical significance of extra-thyroid
    Long B; Yao LF; Chen SC; Shui J; Ye XM; Yi HQ; Lou C
    J Int Med Res; 2021 May; 49(5):3000605211012667. PubMed ID: 34024177
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Giovanella L; Paone G; Ruberto T; Ceriani L; Trimboli P
    Endocrinol Metab (Seoul); 2019 Mar; 34(1):63-69. PubMed ID: 30784242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative remnant
    Lan W; Gege Z; Ningning L; Qiang W; Lin B; Qingjie M; Bin J
    Ann Nucl Med; 2019 Feb; 33(2):112-118. PubMed ID: 30374858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation.
    Thientunyakit T; Pusuwan P; Tuchinda P; Khiewvan B
    J Med Assoc Thai; 2013 Sep; 96(9):1199-207. PubMed ID: 24163997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postsurgical thyroid remnant estimation by (⁹⁹m) Tc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.
    Giovanella L; Suriano S; Ricci R; Ceriani L; Anton Verburg F
    Head Neck; 2011 Apr; 33(4):552-6. PubMed ID: 20824809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before
    Lou K; Gu Y; Hu Y; Wang S; Shi H
    Hell J Nucl Med; 2018; 21(2):121-124. PubMed ID: 30089313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of post thyroidectomy Tc-99m pertechnetate thyroid scan in patients with differentiated thyroid cancer.
    Eloteify LM; Algizawy SM; Abdelnaim AKM; Mekkawy N
    Nucl Med Commun; 2023 Jan; 44(1):38-43. PubMed ID: 36437547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Tc-99m pertechnetate for remnant scintigraphy, post-thyroidectomy, and serum thyroglobulin and antithyroglobulin antibody levels in the patients with differentiated thyroid cancer.
    Aydin F; Sipahi M; Budak ES; Oner AO; Demirelli S; Erkilic M; Gungor F
    Ann Nucl Med; 2016 Jan; 30(1):60-7. PubMed ID: 26462671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer.
    Ozdemir D; Cuhaci FN; Ozdemir E; Aydin C; Ersoy R; Turkolmez S; Cakir B
    Nucl Med Commun; 2016 Jun; 37(6):640-5. PubMed ID: 26895488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFFECT OF POST-SURGICAL RAI THERAPY ON PARATHYROID FUNCTION IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
    Zhang A; Li P; Liu Q; Peng S; Huang G; Song S
    Endocr Pract; 2020 Apr; 26(4):416-422. PubMed ID: 31968192
    [No Abstract]   [Full Text] [Related]  

  • 11. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma.
    Campbell CM; Khafagi FA
    Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from 131I therapy: A prospective observational study.
    Liu M; Chai L; Luo Q; Ruan M; Cheng L; Lv Z; Chen L
    Medicine (Baltimore); 2017 Aug; 96(33):e7631. PubMed ID: 28816945
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhao L; Zhang W; Xin Y; Wen Q; Bail L; Guan F; Bin J
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):349-353. PubMed ID: 30413358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrathyroidal uptake from thyroid carcinoma on 99mTc-pertechnetate scintigraphy.
    Khan SU; Khan AU; Khan A; Shah AS; Khan K
    J Coll Physicians Surg Pak; 2011 Dec; 21(12):772-4. PubMed ID: 22166703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tc-99m imaging in thyroidectomized differentiated thyroid cancer patients immediately before I-131 treatment.
    Tsai CJ; Cheng CY; Shen DH; Kuo SJ; Wang LY; Lee CH; Wang JJ; Chang MC; Huang WS
    Nucl Med Commun; 2016 Feb; 37(2):182-7. PubMed ID: 26626550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of [
    Xu Q; Liu R; Wang J; Huang Y; Li S; Zhang L; Wang F
    Nucl Med Biol; 2020; 88-89():34-43. PubMed ID: 32688289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.
    Klain M; Maurea S; Cuocolo A; Colao A; Marzano L; Lombardi G; Salvatore M
    Eur J Nucl Med; 1996 Dec; 23(12):1568-74. PubMed ID: 8929309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected
    Liu J; Li X; Li L; Yin Y; Cai H; Yi H
    Am J Nucl Med Mol Imaging; 2024; 14(1):63-71. PubMed ID: 38500743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic insular thyroid carcinoma: visualized on Tc-99m pertechnetate, Tc-99m MDP and iodine-131 scintigraphy; a review of the literature for other radionuclide agents.
    Kiratli PO; Kara PP; Ergün EL; Gedikoğlu G
    Ann Nucl Med; 2004 Jul; 18(5):443-6. PubMed ID: 15462407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m methoxyisobutylisonitrile imaging in the follow-up of differentiated thyroid carcinoma.
    Sriprapaporn J; Toopmongkol C; Satayaban B; Chantamoon N
    Ann Acad Med Singap; 2002 Mar; 31(2):195-8. PubMed ID: 11957557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.